Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBC’s Drug Discovery & Development of Innovative Therapeutics Conference
June 30th, 2008
Joseph B. Bolen, Ph.D., CSO of Millennium Pharmaceuticals, will chair the Focus on Cancer track IBC
Life Sciences Drug Discovery & Development of Innovative Therapeutics Conference and Exhibition taking place August 4-7 at the World Trade Center Boston & Seaport Hotel in Boston, MA. The cancer track presentations will focus on therapies for Hematology, Lung Cancer, Blood Borne Cancers, and Clinical Biomarkers.